Abstract
BackgroundThe level of tumor-infiltrating lymphocytes (TILs) is a predictive and prognostic factor for improved clinical outcomes in breast cancer. To identify immune cell subtypes associated with the level of TILs,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
